|
President’s Task Force on Environmental Health and Safety Risks to Children; Goal 5: Support research to improve our scientific understanding and inform decision making; Lead Subcommittee
|
Committee, Work group, Advisory group, or Task Force
|
ACF, CDC, FDA, HRSA, OS
|
NICHD, NHLBI, NIEHS
|
The President''s Task Force on Environmental Health and Safety Risks to Children is the focal point for coordinating the federal government''s effort to explore, understand, and improve children''s environmental health. The task force''s objectives are to: 1) develop federal interagency strategies to protect children’s environmental health and safety; 2) identify priority children''s environmental health and safety issues best addressed through federal interagency efforts; and 3) communicate information to federal, state, and local decision-makers to protect children from environmental health risks. The Lead Subcommittee seeks to reduce lead exposure and associated harms through collaboration among federal agencies and with a range of stakeholders, including states, tribes and local communities, along with businesses, property owners and parents. This Subcommittee will help federal agencies work strategically and collaboratively to reduce exposure to lead with the aim of ultimately improving children’s health.
|
|
Preventing HIV in Adolescent Girls and Young Women Taskforce
|
Committee, Work group, Advisory group, or Task Force
|
CDC, HRSA
|
NICHD
|
In August 2014, the “Preventing HIV in Adolescent Girls and Young Women Task Force” was formed in response to a request from the Office of the Global AIDS Coordinator (OGAC) to articulate PEPFAR/South Africa’s strategy to address the high rates of HIV incidence and infection in 15-24 year old females. Despite slight HIV prevalence declines over the past decade, young South African women continue to experience rapid increases in HIV infection rates beginning in late adolescence. Declining HIV knowledge and increased risk behavior, despite significant treatment scale up and the availability of new prevention tools, are concerning trends among young women. Representatives from NICHD, CDC, and other government agencies joined the OGAC-led task force to develop the strategy and implementation plan. In December 2014, PEPFAR launched the DREAMS initiative: DREAMS is an ambitious partnership to reduce HIV infections among adolescent girls and young women in 10 sub-Saharan African countries. The goal of DREAMS is to help girls develop into Determined, Resilient, Empowered, AIDS-free, Mentored and Safe women.
|
|
Prevention Research Centers
|
Research Initiative
|
CDC
|
NCI
|
The Prevention Research Centers program funds community-based research projects at 26 academic research centers across the United States. These centers: (1) Conduct research projects that promote health and prevent disease; (2) Build research teams of multidisciplinary faculty; (3) Seek solutions, strategies, and policies that address public health problems; (4) Participate in research networks that address priority health issues, such as healthy aging, cancer prevention & control, and obesity prevention; (5) Build long-term relationships for engaging communities as partners in research; (6) Conduct research in directions guided by advisory boards of community leaders; (7) Develop and deliver trainings that enhance the public health workforce; and (8) Conduct additional research funded by other federal agencies, foundations, and nonprofit organizations.
|
|
Prevention Research Coordinating Committee (PRCC)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, OS
|
OD/DPCPSI/ODP, CC, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI/OAR, OD/DPCPSI/OBSSR, OD/DPCPSI/ODS, OD/DPCPSI/ORWH, OD/OLPA
|
The NIH Prevention Research Coordinating Committee (PRCC) serves as a venue for exchanging information on recent scientific advances in disease prevention; examining the impact of new policies on research; planning new or discussing ongoing initiatives; and highlighting program accomplishments. As a trans-NIH, trans-agency committee, the PRCC provides a broad perspective on the current state-of-the-science and actively disseminates information about prevention-related activities sponsored by federal and non-federal organizations to the NIH Institutes and Centers.
|
|
Priorities for National HIV/AIDS Strategy 2020 Research and Programmatic Agenda for Mental Health and Substance Use Concerns
|
Committee, Work group, Advisory group, or Task Force
|
CDC, HRSA, SAMHSA
|
NIMH, NIAID, NIDA
|
The Department of Health and Human Services (HHS) Interagency HIV, Mental Health, and Substance Use Concerns Work Group, which grew out of the National HIV/AIDS Strategy (NHAS), updated to 2020, includes participation from the Centers for Disease Control and Prevention (CDC), Health Services Resources Administration (HRSA), Substance Abuse and Mental Health Services Administration (SAMHSA), and National Institutes of Health (NIH). The workgroup identified priorities within four themes: (1) Screening; (2) Integrated Care and Prevention Services; (3) Anti-Stigma/Anti-Discrimination; and, (4) Addressing the Special Needs of Key Populations and Other Populations Heavily Affected by HIV. Priorities were written broadly to allow assessment, assurance, policy, and research strategies to be developed as needed or prioritized by each agency. Improving prevention and treatment outcomes for HIV, mental and substance use disorders, co-occurring disorders, and other problems is inherent in all priorities, as well. HIV prevention is focused on communities and populations with increased HIV incidence and prevalence, and HIV care and treatment is aimed at the HIV care continuum from testing to viral suppression and continued care. Research goals include developing and testing novel and innovative interventions. Another focus is delivery of evidence-based services and practices to the relevant communities and populations.
|
|
Project ECHO for Cancer Research and Control
|
Other
|
CDC
|
NCI
|
Project ECHO is a collaborative medical education model that aims to build workforce and knowledge capacity, through use of online videoconferencing to allow for knowledge exchange across interdisciplinary teams on relevant medical, healthcare, and health systems related topics. The CGH Project Echo Cancer Control Planning Program will link participants active in cancer control planning in low- and middle-income country settings with researchers, regional colleagues, and relevant technical experts, through monthly ECHO sessions that will provide virtual didactic instruction, case study learning, and knowledge exchange on relevant evidence-based cancer control planning principles. These sessions will relay evidence-based, general cancer control principals and related to cervical cancer screening. The CGH Project ECHO program’s primary goals are to increase participant knowledge of the aforementioned topics, improve the application of knowledge, including evidence-based practices and policies, and to increase collaboration among participants and experts who are active in cancer control planning in the participating countries.
|
|
Promoting Semantic Interoperability of Laboratory Data Test Results
|
Resource Development
|
CDC, FDA
|
NLM
|
The Centers for Disease Control and Prevention (CDC) and the National Library of Medicine (NLM) encourage considering ways that the Food and Drug Administration (FDA) could accelerate specifications of LOINC codes that apply to each test result that a lab/test instrument or kit can generate. Availability of the right LOINC codes with each instrument test kit will greatly simplify the correct assignment of codes by a laboratory for sending to clinician''s medical record system.
|
|
Public Health and Emergency Medical Countermeasures Enterprise (PHEMCE)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, CDC, FDA, OS, SAMHSA
|
NIAID, NIAMS, NICHD, NINDS, NLM
|
The Public Health and Emergency Medical Countermeasures Enterprise (PHEMCE) advances national preparedness for natural, accidental, and intentional threats by coordinating medical countermeasure-related efforts within the Department of Health and Human Services (HHS) and in cooperation with PHEMCE interagency partners. The National Institute of Allergy and Infectious Diseases (NIAID) has representatives on many groups within PHEMCE.
|
|
Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Chemical Integrated Product Development Team (IPT)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
NINDS, NIAID
|
The US Department of Health and Human Services (HHS) Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) leads the mission to develop and acquire medical countermeasures that will improve public health emergency preparedness as well as prevent and mitigate the adverse health consequences associated with chemical, biological, radiological and nuclear (CBRN), and naturally occurring threats.
|
|
Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Pediatrics and Obstetrics Integrated Program Team (IPT)
|
Committee, Work group, Advisory group, or Task Force
|
BARDA, CDC, FDA, OS
|
NICHD, NIGMS
|
The Public Health Emergency Medical Countermeasures Enterprise''s (PHEMCE) mission is to advance national preparedness for natural, accidental, and intentional threats by coordinating medical countermeasure-related efforts within HHS and in cooperation with PHEMCE interagency partners. The Pediatrics and Obstetrics Integrated Program Team (IPT) provide a complete, end-to-end vision of medical countermeasures for pregnant women, mothers, and their children. The IPT considers requirement-analysis, development and production, stockpiling, delivery and dispensing to the end user, adverse event monitoring, communications, guidance and policy development, and evaluating medical countermeasures'' effectiveness and replacement needs.
|